Krystal Biotech (KRYS) Selected as a 'Top Pick' for 2021 by Chardan Capital, Sees 3-4 Major Catalysts
Tweet Send to a Friend
Chardan analyst Gbola Amusa has selected Krystal Biotech (NASDAQ: KRYS) as their “Top Pick” for 2021 as he believes 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
